Coagulation activation-induced fibrinolysis biomarker changes depend on thrombophilic risk factors and their clinical phenotype: an interventional in vivo study
Sara Reda, Nadine Schwarz, Jens Müller…·Heiko Rühl
This study examines how fibrinolysis biomarkers change after rFVIIa-induced coagulation activation in patients with thrombophilia, showing prolonged alterations compared to anticoagulant responses.